Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0697 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0291 | 0.0705 | 0.0705 |
Echinococcus granulosus | acetylcholinesterase | 0.056 | 0.6862 | 0.6862 |
Echinococcus granulosus | carboxylesterase 5A | 0.056 | 0.6862 | 0.6862 |
Echinococcus multilocularis | acetylcholinesterase | 0.056 | 0.6862 | 0.6862 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.056 | 0.6862 | 0.0596 |
Loa Loa (eye worm) | hypothetical protein | 0.0261 | 0.0024 | 0.0024 |
Echinococcus multilocularis | small conductance calcium activated potassium | 0.0697 | 1 | 1 |
Plasmodium falciparum | choline kinase | 0.026 | 0 | 0.5 |
Loa Loa (eye worm) | carboxylesterase | 0.056 | 0.6862 | 0.6862 |
Echinococcus granulosus | acetylcholinesterase | 0.056 | 0.6862 | 0.6862 |
Brugia malayi | Carboxylesterase family protein | 0.056 | 0.6862 | 1 |
Loa Loa (eye worm) | acetylcholinesterase 1 | 0.056 | 0.6862 | 0.6862 |
Schistosoma mansoni | hypothetical protein | 0.0697 | 1 | 1 |
Brugia malayi | Carboxylesterase family protein | 0.056 | 0.6862 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.056 | 0.6862 | 0.6862 |
Loa Loa (eye worm) | hypothetical protein | 0.056 | 0.6862 | 0.6862 |
Echinococcus multilocularis | acetylcholinesterase | 0.056 | 0.6862 | 0.6862 |
Echinococcus multilocularis | carboxylesterase 5A | 0.056 | 0.6862 | 0.6862 |
Plasmodium vivax | choline kinase, putative | 0.026 | 0 | 0.5 |
Schistosoma mansoni | calcium-activated potassium channel | 0.0697 | 1 | 1 |
Toxoplasma gondii | phosphotransferase enzyme family protein | 0.026 | 0 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.